Injury, mass tort and class action cases in federal court, 2020 to 2025
What happened to personal injury cases, mass torts and class actions over the six years 2020 to 2025: how many were filed, how they ended, how long they took, and what our case path model estimates for cases like them.
Every figure carries one of three labels: Sourced (printed by the source), Computed (counted by us from the source's records) or Estimated (produced by a named method of ours and always shown as a range). A dash means the figure is not available. Download this report as a text file. See also the three-year review, 2023 to 2025.
Main findings
- Federal personal injury filings (outside multidistrict litigation) were 23,638 in 2020, 21,333 in 2021, 21,433 in 2022, 28,851 in 2023, 25,423 in 2024 and 26,757 in 2025, against 25,716 in 2019.
- Trials are rare: 144 federal personal injury cases were decided at trial in 2020 and 186 in 2025, 1.1% of resolved cases over the six years.
- The median time from filing to closing rose from 298 days in 2020 to 317 days in 2025.
- A recorded settlement is the most common ending (47.9% of resolved cases over the six years); a further 18.7% were dismissed voluntarily, which often follows a settlement.
- The Panel created 132 new multidistrict litigations in the six years: 26 in 2020, 19 in 2021, 22 in 2022, 20 in 2023, 24 in 2024 and 21 in 2025.
- Company filings disclose 12 settlement amounts tied to these litigations since 2020; the largest single amount stated was $10,300,000,000.
- Federal courts closed 554,974 multidistrict litigation cases in the six years, but 393,875 of them belonged to a single litigation (3M Combat Arms Earplug Products Liability Litigation).
- On 2 November 2026, 204,987 cases were pending in 164 open litigations; products liability litigations held 94.0% of them.
- 66 of the 538,957 multidistrict cases resolved in the six years were decided at trial.
- Judges had served a median of 10.3 years on their court when the Panel assigned them one of today's pending litigations.
- Across 609 judges with at least 100 personal injury cases on file, the middle half had between 40.3% and 63.7% of cases recorded as settled and a median time to closing between 276 and 387 days.
- The Panel's 164 pending litigations are before 142 judges; 19 judges have more than one.
- Class action filings in federal court were 10,230 in 2020, 9,523 in 2021, 9,260 in 2022, 9,691 in 2023, 9,655 in 2024 and 10,589 in 2025.
- The share of class cases recorded as settled fell from 32.2% of resolved cases in 2020 to 24.8% in 2025; the share dismissed voluntarily rose from 32.1% to 38.5%.
- Our case path model, tested against 2020 to 2025, held the actual result inside its range 88% of the time, with a typical gap of 2.5 percentage points.
- For a federal personal injury case, the model estimates 47.9% are recorded as settled (range 45.1% to 51.4%), 52.8% are resolved within a year (range 42.5% to 61.1%) and 83.8% within two years (range 76.7% to 89.7%).
- Federal personal injury cases where the plaintiff had a lawyer were recorded as settled 51.8% of the time; where the plaintiff had no lawyer, 7.1%, with 60.2% dismissed by the court.
- Our case tree model estimates that plaintiffs win 55.4% of federal personal injury trials (range 52.4% to 58.4%) but 7.7% of decisions on a motion before trial (range 5.9% to 9.3%).
- After a judgment for the defendant, an estimated 28.4% of cases are appealed (range 24.2% to 32.8%); after a judgment for the plaintiff, 14.9% (range 10.3% to 20.0%).
- Our filings outlook estimates about 27,755 federal personal injury filings in 2026 (range 25,191 to 29,874), against 26,757 in 2025, and about 11,864 class action filings (range 11,025 to 12,526), against 10,589.
Personal injury cases
Federal courts recorded 147,435 new personal injury cases from 2020 to 2025, not counting cases that were part of a multidistrict litigation (those are covered in the next section). Filings were 23,638 in 2020, 21,333 in 2021, 21,433 in 2022, 28,851 in 2023, 25,423 in 2024 and 26,757 in 2025; the year before the period, 2019, saw 25,716.
Federal personal injury cases, year by yearComputed
| Measure | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change, 2020 to 2025 |
|---|---|---|---|---|---|---|---|
| Cases filed | 23,638 | 21,333 | 21,433 | 28,851 | 25,423 | 26,757 | +13.2% |
| Cases closed | 21,257 | 21,900 | 21,632 | 22,405 | 23,117 | 23,294 | +9.6% |
| Cases resolved in the court | 18,086 | 19,013 | 19,038 | 19,507 | 20,279 | 20,904 | +15.6% |
| Decided at trial | 144 | 269 | 271 | 220 | 214 | 186 | +29.2% |
| Share decided at trial | 0.80% | 1.41% | 1.42% | 1.13% | 1.06% | 0.89% | — |
| Median days from filing to closing | 298 | 357 | 388 | 345 | 327 | 317 | +6.4% |
| Plaintiff win share at trial, where the court recorded who won | 59.2% (142 trials) | 54.6% (260 trials) | 53.9% (269 trials) | 56.9% (218 trials) | 56.5% (207 trials) | 55.7% (183 trials) | — |
Excludes cases flagged as part of a multidistrict litigation. 'Resolved in the court' leaves out cases transferred or sent back to another court.
Federal personal injury cases filed per year
Computed2015 to 2025
Show these numbers as a table
| Year | Federal personal injury cases filed per year |
|---|---|
| 2015 | 17,973 |
| 2016 | 18,696 |
| 2017 | 20,210 |
| 2018 | 20,660 |
| 2019 | 25,716 |
| 2020 | 23,638 |
| 2021 | 21,333 |
| 2022 | 21,433 |
| 2023 | 28,851 |
| 2024 | 25,423 |
| 2025 | 26,757 |
Very few of these cases reach a trial: 144 in 2020, 269 in 2021, 271 in 2022, 220 in 2023, 214 in 2024 and 186 in 2025, or 1.1% of the cases resolved over the six years. The largest single ending is a recorded settlement (47.8% of resolved cases in 2020, 46.7% in 2025). The share dismissed by the court rose from 21.4% to 23.1%.
How federal personal injury cases endedComputed
| How the case ended | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | All six years together |
|---|---|---|---|---|---|---|---|
| Cases resolved in the court | 18,086 | 19,013 | 19,038 | 19,507 | 20,279 | 20,904 | 116,827 |
| Recorded as settled | 8,638 (47.8%) | 9,473 (49.8%) | 9,084 (47.7%) | 9,548 (48.9%) | 9,470 (46.7%) | 9,755 (46.7%) | 47.9% |
| Dismissed voluntarily | 3,247 (18.0%) | 3,510 (18.5%) | 3,308 (17.4%) | 3,679 (18.9%) | 4,022 (19.8%) | 4,044 (19.3%) | 18.7% |
| Dismissed by the court | 3,863 (21.4%) | 3,576 (18.8%) | 4,313 (22.7%) | 4,082 (20.9%) | 4,551 (22.4%) | 4,820 (23.1%) | 21.6% |
| Decided on a motion before trial | 1,183 (6.5%) | 1,083 (5.7%) | 1,005 (5.3%) | 953 (4.9%) | 975 (4.8%) | 928 (4.4%) | 5.2% |
| Decided at trial | 144 (0.8%) | 269 (1.4%) | 271 (1.4%) | 220 (1.1%) | 214 (1.1%) | 186 (0.9%) | 1.1% |
| Other judgment | 399 (2.2%) | 432 (2.3%) | 485 (2.5%) | 476 (2.4%) | 532 (2.6%) | 525 (2.5%) | 2.4% |
| Closed administratively | 539 (3.0%) | 651 (3.4%) | 555 (2.9%) | 524 (2.7%) | 491 (2.4%) | 636 (3.0%) | 2.9% |
| Other or not recorded | 73 (0.4%) | 19 (0.1%) | 17 (0.1%) | 25 (0.1%) | 24 (0.1%) | 10 (under 0.1%) | 0.1% |
Counts, with the share of that year's resolved cases in brackets. Endings are as the courts recorded them. Courts record 'settled' unevenly, and a voluntary dismissal often follows a settlement; the record does not say which.
The median time from filing to closing rose from 298 days in 2020 to 317 days in 2025.
How long federal personal injury cases tookComputed
| Resolved | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Within 6 months | 33.1% | 24.7% | 24.1% | 28.9% | 28.8% | 30.8% |
| Within 12 months | 60.0% | 51.2% | 47.2% | 52.7% | 55.7% | 56.5% |
| Within 24 months | 87.8% | 83.9% | 80.0% | 82.5% | 85.8% | 86.5% |
| Within 36 months | 95.9% | 95.6% | 93.2% | 93.0% | 94.2% | 93.9% |
Share of the cases resolved in each year that had been filed no more than that long before.
By kind of case, 2020 to 2025 togetherComputed
| Kind of case | Filed | Resolved | Recorded as settled | Dismissed voluntarily | Dismissed by the court | Decided at trial | Median days to closing, 2025 |
|---|---|---|---|---|---|---|---|
| Motor vehicle | 35,974 | 30,708 | 58.0% | 18.9% | 16.6% | 1.27% | 326 |
| Motor vehicle product liability | 1,554 | 1,266 | 47.0% | 16.3% | 22.4% | 1.66% | 292 |
| Medical malpractice | 5,692 | 5,264 | 35.5% | 17.3% | 28.9% | 2.83% | 422 |
| Product liability | 18,914 | 11,351 | 39.9% | 28.0% | 21.6% | 0.76% | 396 |
| Health care and pharmaceutical product liability | 5,455 | 4,093 | 32.8% | 19.3% | 34.8% | 0.24% | 569 |
| Asbestos | 744 | 661 | 42.8% | 17.9% | 20.0% | 1.66% | 687 |
| Aviation | 1,531 | 1,387 | 55.8% | 17.4% | 17.2% | 1.08% | 309 |
| Marine | 6,564 | 6,388 | 58.8% | 12.4% | 13.5% | 1.39% | 253 |
| Railroad employee injury | 2,004 | 2,114 | 60.0% | 17.2% | 14.0% | 1.80% | 437 |
| Assault, libel and slander | 3,837 | 3,308 | 14.7% | 16.8% | 45.3% | 1.45% | 205 |
| Other personal injury | 65,166 | 50,287 | 46.2% | 17.6% | 22.7% | 0.89% | 301 |
Shares are of cases resolved in the six years together. Kinds follow the federal courts' own case categories.
Federal personal injury cases in ten large statesComputed
| State | Filed 2020 | Filed 2021 | Filed 2022 | Filed 2023 | Filed 2024 | Filed 2025 | Resolved, 2020 to 2025 | Recorded as settled | Decided at trial | Median days to closing, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| California | 1,789 | 1,518 | 1,419 | 1,803 | 2,313 | 2,400 | 8,211 | 35.2% | 68 | 259 |
| Texas | 2,448 | 2,333 | 2,011 | 2,417 | 2,650 | 3,081 | 11,746 | 40.3% | 113 | 330 |
| Florida | 2,231 | 1,649 | 1,562 | 2,351 | 2,027 | 2,401 | 10,732 | 53.9% | 108 | 204 |
| New York | 1,550 | 1,451 | 1,540 | 1,927 | 1,746 | 1,653 | 7,836 | 42.4% | 60 | 364 |
| Pennsylvania | 1,806 | 1,657 | 1,343 | 1,438 | 1,619 | 1,195 | 7,970 | 45.0% | 58 | 278 |
| Illinois | 1,014 | 1,184 | 2,295 | 3,248 | 1,859 | 1,516 | 6,056 | 39.7% | 42 | 411 |
| Georgia | 954 | 815 | 921 | 986 | 1,083 | 1,237 | 4,755 | 53.4% | 62 | 310 |
| New Jersey | 1,070 | 1,075 | 1,062 | 1,174 | 1,236 | 1,154 | 5,687 | 72.0% | 16 | 284 |
| Ohio | 308 | 319 | 271 | 308 | 284 | 326 | 1,626 | 46.2% | 14 | 313 |
| Michigan | 307 | 301 | 339 | 316 | 363 | 480 | 1,808 | 60.0% | 16 | 410 |
Federal courts sitting in each state. Most injury cases are filed in state courts, which this table does not cover.
State courts handle far more injury cases than federal courts, but few states publish how those cases end. Three of the ten states do, each for its own reporting year, and each only for its most recent published year, so a year-by-year comparison is not possible from these reports.
State courts, latest published year: totals as printedSourced
| State | Kind of case | Reporting year | Filed | Disposed of | Jury verdicts |
|---|---|---|---|---|---|
| California | Other personal injury | 1 July 2024 to 30 June 2025 | 59,077 | 27,620 | 203 |
| California | Motor vehicle | 1 July 2024 to 30 June 2025 | 49,326 | 38,355 | 211 |
| Michigan | Motor vehicle | 1 January 2023 to 31 December 2023 | 19,187 | 20,566 | 83 |
| Michigan | Other personal injury | 1 January 2023 to 31 December 2023 | 4,310 | 4,352 | 66 |
As printed in each state's court statistics report. States define categories differently, so compare within a state, not across states.
State courts, latest published year: totals added up by usComputed
| State | Kind of case | Reporting year | Filed | Disposed of | Jury verdicts |
|---|---|---|---|---|---|
| Texas | Motor vehicle | 1 September 2024 to 31 August 2025 | 66,340 | 69,368 | 364 |
| Texas | Other personal injury | 1 September 2024 to 31 August 2025 | 15,991 | 17,000 | 111 |
| Texas | Medical malpractice | 1 September 2024 to 31 August 2025 | 1,378 | 1,463 | 27 |
| Texas | Product liability | 1 September 2024 to 31 August 2025 | 222 | 258 | 2 |
| Texas | Asbestos | 1 September 2024 to 31 August 2025 | 82 | 120 | 0 |
The state's report prints these by court level; we added the levels together.
One place where payment amounts are public is New York City, which publishes every tort claim its Law Department closes. These are claims against the city itself, not injury cases in general.
Tort claims against New York CityComputed
| Measure | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Matters closed | 6,092 | 4,965 | 5,380 | 5,762 | 6,080 | 5,378 |
| Matters closed with a payment | 3,416 | 3,348 | 3,385 | 3,754 | 3,386 | 3,488 |
| Share closed with a payment | 56.1% | 67.4% | 62.9% | 65.2% | 55.7% | 64.9% |
| Median payment | $25,000 | $25,000 | $30,000 | $30,000 | $35,000 | $32,500 |
| Total paid | $332,069,063 | $500,331,206 | $484,243,057 | $583,778,472 | $573,889,679 | $596,709,121 |
By the year the matter was closed.
Mass torts and multidistrict litigation
A mass tort is usually handled in federal court as a multidistrict litigation: lawsuits filed around the country about the same product or event are sent to one judge for the work before trial. Each person's lawsuit stays a separate case, which is why a single litigation can hold tens of thousands of cases.
Federal courts closed 554,974 cases flagged as multidistrict litigation from 2020 to 2025: 54,554 in 2020, 32,982 in 2021, 90,163 in 2022, 64,804 in 2023, 291,138 in 2024 and 21,333 in 2025. The yearly total swings widely because it depends on when the largest litigations wind down.
Multidistrict litigation cases closed per year
Computed2015 to 2025
Show these numbers as a table
| Year | Multidistrict litigation cases closed per year |
|---|---|
| 2015 | 35,573 |
| 2016 | 43,641 |
| 2017 | 39,025 |
| 2018 | 58,441 |
| 2019 | 69,526 |
| 2020 | 54,554 |
| 2021 | 32,982 |
| 2022 | 90,163 |
| 2023 | 64,804 |
| 2024 | 291,138 |
| 2025 | 21,333 |
One litigation explains the 2024 figure. Of the 291,138 multidistrict cases closed that year, 271,004 carried the docket number of 3M Combat Arms Earplug Products Liability Litigation (MDL No. 2885). Leaving that one litigation out, the yearly totals were 44,367, 27,204, 23,742, 25,155, 20,134 and 20,497.
Litigations with the most cases closed, 2020 to 2025Computed
| Litigation | Closed 2020 | Closed 2021 | Closed 2022 | Closed 2023 | Closed 2024 | Closed 2025 | Closed, six years | Total cases to date (Panel) | Still pending (Panel) |
|---|---|---|---|---|---|---|---|---|---|
| 3M Combat Arms Earplug Products Liability Litigation (MDL No. 2885) | 10,187 | 5,778 | 66,421 | 39,649 | 271,004 | 836 | 393,875 | 391,239 | 2 |
| Xarelto (Rivaroxaban) Products Liability Litigation (MDL No. 2592) | 13,848 | 7,024 | 4,795 | 800 | 62 | 845 | 27,374 | — | — |
| Zantac (Ranitidine) Products Liability Litigation (MDL No. 2924) | 932 | 1,112 | 403 | 12,798 | 20 | 1 | 15,266 | 15,018 | 806 |
| Taxotere (Docetaxel) Products Liability Litigation (MDL No. 2740) | 657 | 646 | 1,196 | 1,306 | 939 | 7,518 | 12,262 | 15,572 | 6 |
| Proton-Pump Inhibitor Products Liability Litigation (No. II) (MDL No. 2789) | 1,941 | 1,158 | 224 | 911 | 752 | 621 | 5,607 | 18,755 | 11,404 |
| Aqueous Film-Forming Foams Products Liability Litigation (MDL No. 2873) | 1 | 134 | 63 | 73 | 3,425 | 840 | 4,536 | 19,846 | 15,270 |
| Paragard IUD Products Liability Litigation (MDL No. 2974) | 2 | 784 | 910 | 900 | 580 | 973 | 4,149 | 4,658 | 4,104 |
| Ethicon Physiomesh Flexible Composite Hernia Mesh Products Liability Litigation (MDL No. 2782) | 32 | 80 | 2,280 | 1,325 | 188 | 24 | 3,929 | 4,054 | 0 |
| Cook Medical, Inc., IVC Filters Marketing, Sales Practices and Products Liability Litigation (MDL No. 2570) | 300 | 853 | 839 | 556 | 483 | 543 | 3,574 | 11,478 | 6,467 |
| Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (MDL No. 3060) | 0 | 0 | 0 | 99 | 1,634 | 1,695 | 3,428 | 17,018 | 12,743 |
| Atrium Medical Corp. C-Qur Mesh Products Liability Litigation (MDL No. 2753) | 15 | 25 | 22 | 726 | 1,579 | 217 | 2,584 | 3,592 | 91 |
| Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (MDL No. 2738) | 266 | 915 | 56 | 20 | 41 | 629 | 1,927 | 72,060 | 69,376 |
| Fosamax (Alendronate Sodium) Products Liability Litigation (No. II) (MDL No. 2243) | 58 | 1 | 954 | 19 | 0 | 400 | 1,432 | 1,294 | 559 |
| Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation (MDL No. 2846) | 91 | 78 | 277 | 262 | 132 | 473 | 1,313 | 25,224 | 23,299 |
| Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation (MDL No. 2973) | 3 | 10 | 48 | 75 | 621 | 549 | 1,306 | 1,989 | 184 |
Yearly closings are counted from the federal case database by docket number; courts do not record the docket number on every case, so these can run below the true figure. The last two columns are the Judicial Panel's own counts on its latest report date. Only litigations named in the Panel's current reports are listed.
How these cases end looks very different from an ordinary injury case. Most are closed by a dismissal. When a litigation is settled as a group, each case is typically closed by a dismissal, so the court record shows a dismissal and not a settlement; the record does not say how many dismissals followed a payment. In 2024, 90.6% of resolved multidistrict cases were voluntary dismissals. Trials are almost unknown: 66 cases were decided at trial in the six years, out of 538,957 resolved.
How multidistrict litigation cases endedComputed
| How the case ended | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | All six years together |
|---|---|---|---|---|---|---|---|
| Cases resolved in the court | 49,619 | 29,333 | 87,794 | 62,541 | 289,598 | 20,072 | 538,957 |
| Recorded as settled | 23,878 (48.1%) | 11,789 (40.2%) | 8,344 (9.5%) | 3,049 (4.9%) | 1,685 (0.6%) | 2,872 (14.3%) | 9.6% |
| Dismissed voluntarily | 9,331 (18.8%) | 10,245 (34.9%) | 19,926 (22.7%) | 19,782 (31.6%) | 262,377 (90.6%) | 7,857 (39.1%) | 61.1% |
| Dismissed by the court | 14,568 (29.4%) | 5,671 (19.3%) | 56,755 (64.6%) | 25,013 (40.0%) | 23,411 (8.1%) | 6,378 (31.8%) | 24.5% |
| Decided on a motion before trial | 1,257 (2.5%) | 685 (2.3%) | 1,435 (1.6%) | 678 (1.1%) | 209 (0.1%) | 297 (1.5%) | 0.8% |
| Decided at trial | 12 (under 0.1%) | 24 (0.1%) | 19 (under 0.1%) | 7 (under 0.1%) | 2 (under 0.1%) | 2 (under 0.1%) | under 0.1% |
| Other judgment | 358 (0.7%) | 28 (0.1%) | 145 (0.2%) | 46 (0.1%) | 624 (0.2%) | 230 (1.1%) | 0.3% |
| Closed administratively | 212 (0.4%) | 890 (3.0%) | 1,169 (1.3%) | 13,963 (22.3%) | 1,290 (0.4%) | 2,436 (12.1%) | 3.7% |
| Other or not recorded | 3 (under 0.1%) | 1 (under 0.1%) | 1 (under 0.1%) | 3 (under 0.1%) | 0 (0.0%) | 0 (0.0%) | under 0.1% |
Counts, with the share of that year's resolved cases in brackets. Endings are as the courts recorded them. Courts record 'settled' unevenly, and a voluntary dismissal often follows a settlement; the record does not say which.
Litigations that drew the most new cases, 2020 to 2025Computed
| Litigation | Filed 2020 | Filed 2021 | Filed 2022 | Filed 2023 | Filed 2024 | Filed 2025 | Filed, six years | Total cases to date (Panel) | Still pending (Panel) |
|---|---|---|---|---|---|---|---|---|---|
| 3M Combat Arms Earplug Products Liability Litigation (MDL No. 2885) | 225,836 | 73,029 | 26,938 | 64,645 | 586 | 12 | 391,046 | 391,239 | 2 |
| Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (MDL No. 2738) | 11,133 | 12,401 | 69 | 16,194 | 4,393 | 10,257 | 54,447 | 72,060 | 69,376 |
| Aqueous Film-Forming Foams Products Liability Litigation (MDL No. 2873) | 799 | 1,225 | 1,682 | 3,742 | 4,157 | 10,135 | 21,740 | 19,846 | 15,270 |
| Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation (MDL No. 2846) | 5,325 | 4,957 | 3,451 | 3,043 | 3,123 | 108 | 20,007 | 25,224 | 23,299 |
| Zantac (Ranitidine) Products Liability Litigation (MDL No. 2924) | 1,026 | 1,077 | 347 | 12,788 | 20 | 2 | 15,260 | 15,018 | 806 |
| Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (MDL No. 3060) | 0 | 0 | 11 | 8,370 | 2,548 | 144 | 11,073 | 17,018 | 12,743 |
| Bair Hugger Forced Air Warming Devices Products Liability Litigation (MDL No. 2666) | 16 | 5,238 | 59 | 1,151 | 1,875 | 1,607 | 9,946 | 10,836 | 8,414 |
| Paragard IUD Products Liability Litigation (MDL No. 2974) | 15 | 771 | 913 | 899 | 581 | 971 | 4,150 | 4,658 | 4,104 |
| Cook Medical, Inc., IVC Filters Marketing, Sales Practices and Products Liability Litigation (MDL No. 2570) | 1,264 | 1,475 | 749 | 264 | 86 | 33 | 3,871 | 11,478 | 6,467 |
| Proton-Pump Inhibitor Products Liability Litigation (No. II) (MDL No. 2789) | 2,025 | 866 | 479 | 147 | 2 | 4 | 3,523 | 18,755 | 11,404 |
| Bard Implanted Port Catheter Products Liability Litigation (MDL No. 3081) | 0 | 0 | 0 | 95 | 947 | 1,793 | 2,835 | 4,636 | 4,345 |
| Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation (MDL No. 3094) | 0 | 0 | 0 | 13 | 1,013 | 1,291 | 2,317 | 4,196 | 4,082 |
| Covidien Hernia Mesh Products Liability Litigation (No. II) (MDL No. 3029) | 0 | 28 | 169 | 734 | 699 | 615 | 2,245 | 2,496 | 2,486 |
| Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation (MDL No. 3140) | 0 | 0 | 0 | 0 | 1 | 2,047 | 2,048 | 6,525 | 6,413 |
| Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation (MDL No. 2973) | 71 | 651 | 1,161 | 99 | 4 | 0 | 1,986 | 1,989 | 184 |
Counted the same way as the table above, with the same limits.
On 2 November 2026, the Judicial Panel on Multidistrict Litigation listed 164 litigations still open, holding 204,987 pending cases out of 719,296 filed in them to date. Products liability litigations, the category that covers drugs, medical devices and consumer products, hold 94.0% of the pending cases.
Open litigations by category, 2 November 2026Computed
| Category | Litigations | Cases pending | Share of pending cases | Total cases to date |
|---|---|---|---|---|
| Products Liability | 65 | 192,725 | 94.0% | 697,030 |
| Miscellaneous | 15 | 8,588 | 4.2% | 10,665 |
| Antitrust | 38 | 1,215 | 0.6% | 2,254 |
| Data Breach and Consumer Privacy | 20 | 1,086 | 0.5% | 1,402 |
| Sales Practices | 9 | 642 | 0.3% | 764 |
| Common Disaster | 3 | 409 | 0.2% | 6,647 |
| Intellectual Property | 7 | 177 | 0.1% | 223 |
| Securities | 4 | 90 | 0.0% | 256 |
| Air Disaster | 2 | 49 | 0.0% | 49 |
| Employment Practices | 1 | 6 | 0.0% | 6 |
| All categories | 164 | 204,987 | 100.0% | 719,296 |
Categories are the Panel's own. We added up the Panel's list by category.
The fifteen largest open litigations, 2 November 2026Sourced
| Litigation | Category | Year centralised | Cases pending | Total cases to date |
|---|---|---|---|---|
| Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (MDL No. 2738) | Products Liability | 2016 | 69,376 | 72,060 |
| Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation (MDL No. 2846) | Products Liability | 2018 | 23,299 | 25,224 |
| Aqueous Film-Forming Foams Products Liability Litigation (MDL No. 2873) | Products Liability | 2018 | 15,270 | 19,846 |
| Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (MDL No. 3060) | Products Liability | 2023 | 12,743 | 17,018 |
| Proton-Pump Inhibitor Products Liability Litigation (No. II) (MDL No. 2789) | Products Liability | 2017 | 11,404 | 18,755 |
| Bair Hugger Forced Air Warming Devices Products Liability Litigation (MDL No. 2666) | Products Liability | 2015 | 8,414 | 10,836 |
| Paraquat Products Liability Litigation (MDL No. 3004) | Products Liability | 2021 | 6,635 | 8,529 |
| Cook Medical, Inc., IVC Filters Marketing, Sales Practices and Products Liability Litigation (MDL No. 2570) | Products Liability | 2014 | 6,467 | 11,478 |
| Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation (MDL No. 3140) | Products Liability | 2025 | 6,413 | 6,525 |
| Uber Technologies, Inc., Passenger Sexual Assault Litigation (MDL No. 3084) | Miscellaneous | 2023 | 4,548 | 5,552 |
| Bard Implanted Port Catheter Products Liability Litigation (MDL No. 3081) | Products Liability | 2023 | 4,345 | 4,636 |
| Social Media Adolescent Addiction/Personal Injury Products Liability Litigation (MDL No. 3047) | Products Liability | 2022 | 4,309 | 4,495 |
| Paragard IUD Products Liability Litigation (MDL No. 2974) | Products Liability | 2020 | 4,104 | 4,658 |
| Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation (MDL No. 3094) | Products Liability | 2024 | 4,082 | 4,196 |
| National Prescription Opiate Litigation (MDL No. 2804) | Miscellaneous | 2017 | 2,877 | 3,184 |
Litigations centralised in 2020 to 2025 that are still openComputed
| Year centralised | Litigations still open | Of which products liability | Cases filed in them to date |
|---|---|---|---|
| 2020 | 7 | 3 | 21,746 |
| 2021 | 12 | 4 | 10,108 |
| 2022 | 17 | 12 | 11,849 |
| 2023 | 12 | 4 | 28,786 |
| 2024 | 18 | 4 | 8,330 |
| 2025 | 19 | 2 | 7,423 |
Counts only litigations still open on the report date. Litigations created in these years that have already closed are not in the Panel's pending report and are not counted.
The Panel's own yearly statistics show how many new litigations it created: 26 in 2020, 19 in 2021, 22 in 2022, 20 in 2023, 24 in 2024 and 21 in 2025. Far more lawsuits arrive later, sent on to a litigation that already exists: 3,114 in 2020, 2,831 in 2021, 2,694 in 2022, 2,079 in 2023, 1,659 in 2024 and 1,300 in 2025.
What the Panel did each yearSourced
| Measure | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Requests to create a litigation filed | 53 | 40 | 45 | 29 | 46 | 32 |
| Requests granted (new litigations created) | 26 | 19 | 22 | 20 | 24 | 21 |
| Requests denied, moot or withdrawn | 29 | 23 | 17 | 12 | 19 | 16 |
| Lawsuits in the requests granted | 396 | 203 | 223 | 232 | 333 | 278 |
| Lawsuits added later to existing litigations | 3,114 | 2,831 | 2,694 | 2,079 | 1,659 | 1,300 |
| Lawsuits sent back by the Panel | 364 | 58 | 21 | 155 | 53 | 53 |
As printed in the Panel's calendar year statistics. These count lawsuits moved by the Panel; many more are filed directly in a litigation's court and are not in these rows.
Month by month, the number of pending lawsuits fell from 325,914 on 2 December 2024 to 204,987 on 2 November 2026; the lowest count in between was 179,268 on 1 April 2025.
Pending litigations and lawsuits, month by monthSourced
| Report date | Litigations pending | Lawsuits pending |
|---|---|---|
| 2 December 2024 | 171 | 325,914 |
| 2 January 2025 | 170 | 302,338 |
| 3 February 2025 | 164 | 278,246 |
| 3 March 2025 | 164 | 212,279 |
| 1 April 2025 | 163 | 179,268 |
| 1 May 2025 | 162 | 182,011 |
| 2 June 2025 | 162 | 184,470 |
| 1 August 2025 | 156 | 193,625 |
| 2 September 2025 | 159 | 196,861 |
| 1 October 2025 | 158 | 197,115 |
| 3 November 2025 | 157 | 197,981 |
| 2 December 2025 | 157 | 198,163 |
| 5 January 2026 | 158 | 197,965 |
| 2 February 2026 | 157 | 197,264 |
| 2 March 2026 | 160 | 198,480 |
| 1 April 2026 | 158 | 198,825 |
| 1 May 2026 | 159 | 199,684 |
| 1 June 2026 | 159 | 202,129 |
| 1 July 2026 | 162 | 203,915 |
| 3 August 2026 | 162 | 205,540 |
| 1 September 2026 | 166 | 206,182 |
| 1 October 2026 | 162 | 204,977 |
| 2 November 2026 | 164 | 204,987 |
The printed totals of each of the Panel's monthly reports that we could read in full. A month is left out if any row of that report could not be read.
Court records do not show what a settlement paid. Public companies, though, must tell investors about large ones. We searched company filings with the Securities and Exchange Commission and found 12 disclosures of a settlement amount tied to one of these litigations since 2020. Each amount is quoted word for word from the filing on the litigation's page. An amount is what the company said on that date: many are conditional, paid over years, cover claims outside the federal litigation, or were later changed, so they should not be added together.
Settlement amounts disclosed in company filings since 2020Sourced
| Litigation | Company filing | Date filed | Amount stated |
|---|---|---|---|
| National Prescription Opiate Litigation (MDL No. 2804) | Walgreens Boots Alliance, Inc., 8-K | 2 November 2022 | $4,790,000,000 |
| National Prescription Opiate Litigation (MDL No. 2804) | Walmart Inc., 8-K | 15 November 2022 | $3,100,000,000 |
| Facebook, Inc., Consumer Privacy User Profile Litigation (MDL No. 2843) | Meta Platforms, Inc., 10-K | 2 February 2023 | $725,000,000 |
| Juul Labs, Inc., Marketing, Sales Practices, and Products Liability Litigation (MDL No. 2913) | Altria Group, Inc., 8-K | 10 May 2023 | $235,000,000 |
| Aqueous Film-Forming Foams Products Liability Litigation (MDL No. 2873) | Chemours Co, 8-K | 2 June 2023 | $1,185,000,000 |
| National Prescription Opiate Litigation (MDL No. 2804) | Teva Pharmaceutical Industries Ltd, 8-K | 8 June 2023 | $4,250,000,000 |
| Aqueous Film-Forming Foams Products Liability Litigation (MDL No. 2873) | 3M Co, 8-K | 22 June 2023 | $10,300,000,000 |
| 3M Combat Arms Earplug Products Liability Litigation (MDL No. 2885) | 3M Co, 8-K | 29 August 2023 | $6,010,000,000 |
| National Prescription Opiate Litigation (MDL No. 2804) | Kroger Co, 8-K | 8 September 2023 | $1,200,000,000 |
| Aqueous Film-Forming Foams Products Liability Litigation (MDL No. 2873) | Johnson Controls International plc, 8-K | 12 April 2024 | $750,000,000 |
| 23andMe, Inc., Customer Data Security Breach Litigation (MDL No. 3098) | 23andMe Holding Co., 8-K | 28 January 2025 | $30,000,000 |
| Xyrem (Sodium Oxybate) Antitrust Litigation (MDL No. 2966) | Jazz Pharmaceuticals plc, 8-K | 8 April 2025 | $145,000,000 |
Only disclosures we found and could verify against the filing are listed; a litigation missing from this table may still have settled. Private companies and most foreign companies do not file these reports.
Large litigations run for many years. To give a sense of scale we measured every finished litigation in the federal case database, from the first case filed to the last case closed, grouped by how many cases it held.
How long finished litigations lastedComputed
| Size of litigation | Finished litigations measured | Median length | Middle half lasted |
|---|---|---|---|
| 100 to 999 cases | 43 | 8 years | 5.5 to 9.5 years |
| 1,000 to 9,999 cases | 10 | 11 years | 9.5 to 12.5 years |
| 10,000 cases or more | Too few to compare | — | — |
A litigation counts as finished when no case carrying its docket number is still pending. A group is shown only when at least ten finished litigations can be measured.
The Panel also reports which litigations have closed altogether. From 1 January 2026 to 2 November 2026, 16 did.
Litigations closed in 2026 so farSourced
| Litigation | Centralised | Closed | Time open |
|---|---|---|---|
| Syngenta AG MIR162 Corn Litigation (MDL No. 2591) | 11 December 2014 | 13 January 2026 | 11.1 years |
| Xarelto (Rivaroxaban) ('310) Patent Litigation (MDL No. 3017) | 10 December 2021 | 3 February 2026 | 4.2 years |
| Xarelto (Rivaroxaban) Products Liability Litigation (MDL No. 2592) | 12 December 2014 | 11 February 2026 | 11.2 years |
| Evolve Bank & Trust Customer Data Security Breach Litigation (MDL No. 3127) | 4 October 2024 | 9 March 2026 | 1.4 years |
| SoClean, Inc., Marketing, Sales Practices and Products Liability Litigation (MDL No. 3021) | 2 February 2022 | 11 March 2026 | 4.1 years |
| Passenger Vehicle Replacement Tires Antitrust Litigation (MDL No. 3107) | 7 June 2024 | 3 April 2026 | 1.8 years |
| Xyrem (Sodium Oxybate) Antitrust Litigation (MDL No. 2966) | 16 December 2020 | 21 April 2026 | 5.3 years |
| Liquid Toppings Dispensing System ('447) Patent Litigation (MDL No. 2832) | 5 April 2018 | 18 June 2026 | 8.2 years |
| SAP SE, et al., Patent Litigation (MDL No. 3158) | 11 August 2025 | 10 July 2026 | 0.9 years |
| Midwest Energy Emissions Corp. Patent Litigation (MDL No. 3132) | 12 December 2024 | 17 August 2026 | 1.7 years |
| AVYCAZ (Ceftazidime and Avibactam) Patent Litigation (MDL No. 3134) | 6 February 2025 | 2 September 2026 | 1.6 years |
| Google Inc. Cookie Placement Consumer Privacy Litigation (MDL No. 2358) | 12 June 2012 | 3 September 2026 | 14.2 years |
| Smith & Nephew Birmingham Hip Resurfacing (BHR) Hip Implant Products Liability Litigation (MDL No. 2775) | 5 April 2017 | 28 September 2026 | 9.5 years |
| Evenflo Company, Inc., Marketing, Sales Practices and Products Liability Litigation (MDL No. 2938) | 2 June 2020 | 30 September 2026 | 6.3 years |
| Blackbaud, Inc., Customer Data Security Breach Litigation (MDL No. 2972) | 15 December 2020 | 8 October 2026 | 5.8 years |
| Generac Solar Power Systems Marketing, Sales Practices and Products Liability Litigation (MDL No. 3078) | 2 June 2023 | 27 October 2026 | 3.4 years |
Dates as printed by the Panel. Time open is computed from the two dates.
Judges handling multidistrict litigation
On 2 November 2026, the Panel's 164 pending litigations were assigned to 142 judges. 19 of them had more than one. The Panel listed 44 as senior district judges and 14 as chief judges of their courts. These are counts of assignments; nothing here describes or assesses how any judge decides cases, and we make no estimates about any judge.
For the 146 litigations where the judge could be matched with certainty to the federal judges' directory, the judge had served a median of 10.3 years on that court when the litigation was assigned; the middle half had served between 4.9 and 17.9 years, and 39 assignments went to a judge with under five years on the court.
Years on the court when the litigation was assignedComputed
| Years served on that court | Litigations assigned | Share |
|---|---|---|
| Under 5 years | 39 | 26.7% |
| 5 to 9 years | 31 | 21.2% |
| 10 to 19 years | 47 | 32.2% |
| 20 years or more | 29 | 19.9% |
From the date the judge was commissioned to the court to the date the Panel sent the litigation there. Litigations whose judge could not be matched with certainty to the directory are left out.
Courts with the most pending litigationsComputed
| Court | Litigations | Judges handling them | Lawsuits pending |
|---|---|---|---|
| Northern District of California | 21 | 15 | 11,177 |
| Southern District of New York | 14 | 13 | 712 |
| Northern District of Illinois | 13 | 12 | 14,408 |
| District of New Jersey | 12 | 9 | 84,948 |
| District of Minnesota | 9 | 6 | 8,831 |
| Eastern District of Pennsylvania | 8 | 6 | 4,783 |
| Central District of California | 7 | 6 | 389 |
| Southern District of Florida | 7 | 6 | 949 |
| District of Massachusetts | 5 | 5 | 2,771 |
| Eastern District of Michigan | 5 | 5 | 62 |
| Northern District of Georgia | 4 | 3 | 4,151 |
| Southern District of California | 4 | 4 | 564 |
The twelve courts with the most litigations on the Panel's pending report.
Judges with more than one pending litigationComputed
| Judge | Court | Litigations | Lawsuits pending in them |
|---|---|---|---|
| Brian R. Martinotti | District of New Jersey | 3 | 2,070 |
| Charles R. Breyer | Northern District of California | 3 | 4,912 |
| Claire C. Cecchi | District of New Jersey | 2 | 11,406 |
| Cynthia M. Rufe | Eastern District of Pennsylvania | 2 | 72 |
| David J. Novak | Eastern District of Virginia | 2 | 4 |
| Denise L. Cote | Southern District of New York | 2 | 117 |
| Donovan W. Frank | District of Minnesota | 2 | 167 |
| Edward J. Davila | Northern District of California | 2 | 17 |
| Haywood S. Gilliam, Jr | Northern District of California | 2 | 30 |
| James V. Selna | Central District of California | 2 | 105 |
| Jane Triche Milazzo | Eastern District of Louisiana | 2 | 141 |
| Jerry W. Blackwell | District of Minnesota | 2 | 96 |
| John R. Tunheim | District of Minnesota | 2 | 91 |
| K. Michael Moore | Southern District of Florida | 2 | 47 |
| Karen S. Marston | Eastern District of Pennsylvania | 2 | 4,360 |
| M. Casey Rodgers | Northern District of Florida | 2 | 6,415 |
| Matthew F. Kennelly | Northern District of Illinois | 2 | 202 |
| Thomas W. Thrash, Jr | Northern District of Georgia | 2 | 47 |
| Vince Chhabria | Northern District of California | 3 | 937 |
Listed alphabetically by first name as the Panel prints it. The order is not a ranking.
Pending lawsuits are concentrated before a few judges: the 5 judges with 10,000 or more pending lawsuits before them account for 64.4% of all pending lawsuits.
For personal injury cases more broadly, a free public source (CourtListener's docket records) names the judge for 95% of the cases resolved from 2016 to 2025. Joining it to the federal case database shows how the cases before each judge ended. We list 996 judges, each with at least 50 such cases, on their own pages. The table below shows how much judges' dockets differ, for the 609 judges with at least 100 cases, without naming or ordering anyone. The differences reflect the mix of cases each judge is assigned as well as anything else.
How much judges' personal injury dockets differ, 2016 to 2025Computed
| Measure, per judge | A quarter of judges are at or below | Middle judge | A quarter of judges are at or above |
|---|---|---|---|
| Share of cases recorded as settled | 40.3% | 52.8% | 63.7% |
| Share of cases dismissed by the court | 9.9% | 17.1% | 25.2% |
| Median days from filing to closing | 276 | 333 | 387 |
Judges with at least 100 resolved personal injury cases on file, outside multidistrict litigation: 609 judges. Counts cover cases with a docket naming the judge on file, not every case.
Class actions
A class action is a single lawsuit brought on behalf of a group. The federal courts record whether a complaint makes class action allegations; that is what is counted here. An allegation is not a certified class, and most of these cases end before a court ever rules on certification.
Federal courts recorded 58,948 new cases with class action allegations from 2020 to 2025: 10,230 in 2020, 9,523 in 2021, 9,260 in 2022, 9,691 in 2023, 9,655 in 2024 and 10,589 in 2025.
Federal cases filed with class action allegations per year
Computed2015 to 2025
Show these numbers as a table
| Year | Federal cases filed with class action allegations per year |
|---|---|
| 2015 | 9,024 |
| 2016 | 7,917 |
| 2017 | 8,984 |
| 2018 | 9,759 |
| 2019 | 10,048 |
| 2020 | 10,230 |
| 2021 | 9,523 |
| 2022 | 9,260 |
| 2023 | 9,691 |
| 2024 | 9,655 |
| 2025 | 10,589 |
The share recorded as settled fell from 32.2% in 2020 to 24.8% in 2025, while the share dismissed voluntarily rose from 32.1% to 38.5%. A voluntary dismissal of a class case can mean the named plaintiff's own claim was resolved without a class-wide settlement; the record does not say how often.
How cases with class action allegations endedComputed
| How the case ended | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | All six years together |
|---|---|---|---|---|---|---|---|
| Cases resolved in the court | 9,407 | 9,254 | 9,021 | 8,436 | 8,338 | 9,492 | 53,948 |
| Recorded as settled | 3,031 (32.2%) | 2,925 (31.6%) | 2,968 (32.9%) | 2,501 (29.6%) | 2,277 (27.3%) | 2,358 (24.8%) | 29.8% |
| Dismissed voluntarily | 3,016 (32.1%) | 3,047 (32.9%) | 2,904 (32.2%) | 2,764 (32.8%) | 2,939 (35.2%) | 3,659 (38.5%) | 34.0% |
| Dismissed by the court | 1,612 (17.1%) | 1,512 (16.3%) | 1,410 (15.6%) | 1,437 (17.0%) | 1,463 (17.5%) | 1,500 (15.8%) | 16.6% |
| Decided on a motion before trial | 797 (8.5%) | 851 (9.2%) | 826 (9.2%) | 641 (7.6%) | 634 (7.6%) | 678 (7.1%) | 8.2% |
| Decided at trial | 21 (0.2%) | 23 (0.2%) | 18 (0.2%) | 28 (0.3%) | 29 (0.3%) | 24 (0.3%) | 0.3% |
| Other judgment | 502 (5.3%) | 533 (5.8%) | 541 (6.0%) | 492 (5.8%) | 469 (5.6%) | 509 (5.4%) | 5.6% |
| Closed administratively | 411 (4.4%) | 353 (3.8%) | 345 (3.8%) | 557 (6.6%) | 515 (6.2%) | 753 (7.9%) | 5.4% |
| Other or not recorded | 17 (0.2%) | 10 (0.1%) | 9 (0.1%) | 16 (0.2%) | 12 (0.1%) | 11 (0.1%) | 0.1% |
Counts, with the share of that year's resolved cases in brackets. Endings are as the courts recorded them. Courts record 'settled' unevenly, and a voluntary dismissal often follows a settlement; the record does not say which.
How long cases with class action allegations tookComputed
| Resolved | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Within 6 months | 43.9% | 47.2% | 48.5% | 49.1% | 46.8% | 51.7% |
| Within 12 months | 62.4% | 66.1% | 65.5% | 67.2% | 65.8% | 68.0% |
| Within 24 months | 78.5% | 83.3% | 80.7% | 82.5% | 81.7% | 83.6% |
| Within 36 months | 85.3% | 90.9% | 89.2% | 90.2% | 89.7% | 91.2% |
Share of the cases resolved in each year that had been filed no more than that long before.
Class certification, where the court recorded a rulingComputed
| Among cases closed in the year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Certification recorded as granted | 963 | 743 | 714 | 700 | 674 | 861 |
| Certification recorded as denied | 615 | 677 | 626 | 726 | 603 | 903 |
| Cases resolved | 9,407 | 9,254 | 9,021 | 8,436 | 8,338 | 9,492 |
Courts record a certification ruling for only a minority of cases, so these counts are a floor and should not be turned into a success rate.
By kind of class action, 2020 to 2025Computed
| Kind | Filed 2020 | Filed 2021 | Filed 2022 | Filed 2023 | Filed 2024 | Filed 2025 | Resolved, 2020 to 2025 | Recorded as settled | Dismissed voluntarily | Dismissed by the court | Decided on a motion before trial |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Disability access | 1,965 | 2,306 | 2,642 | 2,243 | 1,749 | 1,248 | 12,516 | 38.7% | 49.8% | 8.0% | 0.8% |
| Wage, hour and labor | 1,727 | 1,423 | 1,660 | 1,539 | 1,447 | 1,679 | 8,981 | 43.8% | 18.9% | 12.8% | 6.7% |
| Contract | 1,335 | 929 | 847 | 1,073 | 1,376 | 1,313 | 5,649 | 17.9% | 29.3% | 22.7% | 12.1% |
| Fraud and property damage | 799 | 867 | 891 | 1,129 | 1,104 | 1,154 | 5,188 | 14.4% | 39.6% | 21.3% | 11.7% |
| Other | 1,381 | 886 | 806 | 802 | 693 | 1,245 | 5,482 | 21.9% | 30.7% | 22.2% | 14.8% |
| Personal injury | 440 | 564 | 538 | 1,019 | 985 | 1,163 | 3,314 | 13.4% | 36.6% | 26.0% | 6.9% |
| Telephone consumer protection | 253 | 450 | 412 | 539 | 722 | 1,479 | 2,918 | 27.9% | 54.2% | 12.4% | 1.6% |
| Consumer credit | 1,133 | 1,045 | 536 | 349 | 284 | 206 | 4,100 | 43.7% | 28.9% | 13.5% | 7.7% |
| Other civil rights | 420 | 379 | 403 | 495 | 492 | 526 | 2,227 | 26.9% | 17.3% | 25.1% | 16.8% |
| Securities | 457 | 393 | 285 | 302 | 313 | 278 | 1,928 | 9.6% | 22.7% | 21.9% | 22.2% |
| Antitrust | 180 | 161 | 114 | 118 | 368 | 159 | 1,084 | 32.3% | 11.8% | 31.0% | 8.9% |
| Employee benefit (ERISA) | 140 | 120 | 126 | 83 | 122 | 139 | 561 | 25.3% | 12.5% | 16.0% | 21.9% |
Kinds are our grouping of the federal courts' case categories. Shares are of cases resolved in the six years together.
Class action filings in ten large statesComputed
| State | Filed 2020 | Filed 2021 | Filed 2022 | Filed 2023 | Filed 2024 | Filed 2025 | Filed, 2020 to 2025 |
|---|---|---|---|---|---|---|---|
| California | 2,386 | 1,932 | 1,654 | 1,927 | 2,007 | 3,032 | 12,938 |
| Texas | 359 | 307 | 257 | 304 | 514 | 492 | 2,233 |
| Florida | 226 | 299 | 151 | 126 | 162 | 218 | 1,182 |
| New York | 3,298 | 3,519 | 3,731 | 3,332 | 2,690 | 2,173 | 18,743 |
| Pennsylvania | 395 | 351 | 400 | 440 | 511 | 462 | 2,559 |
| Illinois | 69 | 112 | 92 | 98 | 88 | 71 | 530 |
| Georgia | 132 | 153 | 131 | 210 | 270 | 291 | 1,187 |
| New Jersey | 494 | 475 | 353 | 338 | 421 | 318 | 2,399 |
| Ohio | 394 | 275 | 264 | 274 | 239 | 268 | 1,714 |
| Michigan | 201 | 199 | 258 | 200 | 205 | 264 | 1,327 |
Federal courts sitting in each state.
Our case path model
The case path model is our own. For one kind of case in one place, it estimates how such cases tend to end and how long they tend to take. It is built only from cases the federal courts have already resolved, over the five years from 2021 to 2025, and it currently covers 131 combinations of place and kind of case. Every figure it produces is an estimate, shown as a value with a range, and is labelled as one wherever it appears.
It describes cases as a group. It does not predict what will happen in any one person's case, it says nothing about any named firm, attorney, person or litigation, and it does not estimate amounts.
Case path estimates: personal injury, nationwideEstimated
| Kind of case | Recorded as settled | Dismissed voluntarily | Dismissed by the court | Decided on a motion before trial | Decided at trial | Resolved within 12 months | Resolved within 24 months | Resolved cases the estimate rests on |
|---|---|---|---|---|---|---|---|---|
| Personal injury (all types) | 47.9% (45.1% to 51.4%) | 18.8% (16.1% to 21.1%) | 21.6% (16.7% to 25.2%) | 5.0% (3.8% to 6.3%) | 1.2% (0.6% to 1.7%) | 52.8% (42.5% to 61.1%) | 83.8% (76.7% to 89.7%) | 98,741 |
| Motor vehicle | 57.8% (55.5% to 60.7%) | 18.9% (17.5% to 20.9%) | 16.9% (12.9% to 20.1%) | 2.0% (1.4% to 2.5%) | 1.3% (0.8% to 1.7%) | 53.9% (48.6% to 59.4%) | 88.4% (84.1% to 92.5%) | 26,473 |
| Motor vehicle product liability | 47.7% (40.4% to 54.1%) | 15.6% (9.9% to 21.9%) | 22.2% (13.6% to 29.3%) | 7.0% (5.0% to 9.2%) | 1.7% (0.3% to 3.4%) | 50.4% (32.1% to 66.5%) | 78.8% (66.9% to 87.9%) | 1,048 |
| Medical malpractice | 35.9% (28.2% to 41.9%) | 17.8% (12.1% to 24.4%) | 28.0% (18.1% to 43.4%) | 9.1% (5.3% to 13.2%) | 3.0% (0.7% to 5.8%) | 42.4% (35.0% to 50.6%) | 72.0% (67.9% to 76.5%) | 4,301 |
| Product liability | 38.4% (17.5% to 56.2%) | 29.9% (10.5% to 48.1%) | 22.0% (8.3% to 37.4%) | 4.1% (1.8% to 6.9%) | 0.8% (0.5% to 1.1%) | 47.5% (37.3% to 61.8%) | 76.9% (68.1% to 85.6%) | 9,643 |
| Health care and pharmaceutical product liability | 30.1% (0.0% to 62.1%) | 19.9% (7.8% to 34.1%) | 39.0% (3.1% to 80.2%) | 4.5% (0.1% to 10.2%) | 0.3% (0.0% to 0.9%) | 39.5% (14.0% to 71.6%) | 64.8% (40.8% to 96.1%) | 3,345 |
| Asbestos | 43.4% (35.5% to 50.5%) | 18.0% (10.7% to 28.5%) | 19.5% (2.8% to 33.6%) | 4.4% (0.0% to 12.7%) | 1.7% (0.0% to 7.4%) | 31.6% (14.4% to 48.0%) | 66.9% (49.0% to 80.9%) | 544 |
| Aviation | 54.9% (48.9% to 64.2%) | 17.1% (14.1% to 21.0%) | 17.5% (5.1% to 29.0%) | 4.4% (0.8% to 7.8%) | 1.3% (0.0% to 2.6%) | 43.8% (17.7% to 70.5%) | 70.8% (34.2% to 100.0%) | 1,140 |
| Marine | 60.4% (55.2% to 66.0%) | 12.3% (9.2% to 14.8%) | 13.3% (6.3% to 21.9%) | 3.6% (0.5% to 7.2%) | 1.4% (0.0% to 3.4%) | 58.6% (29.6% to 80.1%) | 84.8% (73.2% to 95.4%) | 5,336 |
| Railroad employee injury | 60.7% (50.4% to 70.6%) | 17.2% (6.0% to 32.4%) | 14.0% (9.2% to 20.2%) | 3.9% (1.9% to 6.1%) | 2.0% (0.7% to 3.3%) | 37.0% (30.0% to 45.0%) | 74.0% (65.7% to 82.1%) | 1,790 |
| Assault, libel and slander | 14.6% (9.5% to 19.6%) | 16.8% (11.2% to 26.1%) | 45.7% (38.3% to 53.1%) | 13.4% (10.9% to 16.0%) | 1.6% (0.4% to 3.0%) | 67.6% (60.2% to 73.1%) | 87.4% (82.7% to 91.5%) | 2,776 |
| Other personal injury | 46.6% (41.9% to 50.1%) | 17.4% (13.7% to 20.9%) | 22.4% (18.9% to 25.4%) | 6.4% (4.4% to 8.7%) | 1.0% (0.3% to 1.6%) | 54.8% (44.2% to 64.5%) | 86.0% (80.8% to 90.4%) | 42,345 |
Each cell is the model's value with its range in brackets. Method: case path model, version 2. Inputs: yearly counts of resolved federal cases, 2021 to 2025.
Case path estimates: personal injury in ten large statesEstimated
| State | Recorded as settled | Dismissed voluntarily | Dismissed by the court | Decided on a motion before trial | Decided at trial | Resolved within 12 months | Resolved within 24 months | Resolved cases the estimate rests on |
|---|---|---|---|---|---|---|---|---|
| California | 35.6% (24.9% to 48.4%) | 27.6% (16.3% to 40.5%) | 23.9% (20.3% to 27.8%) | 5.2% (2.3% to 7.4%) | 0.9% (0.2% to 1.6%) | 56.6% (41.7% to 71.8%) | 81.7% (70.7% to 94.1%) | 7,120 |
| Texas | 40.1% (34.8% to 45.1%) | 16.9% (12.2% to 21.5%) | 29.6% (20.6% to 36.8%) | 4.6% (2.8% to 7.4%) | 1.0% (0.3% to 1.9%) | 52.6% (47.3% to 57.7%) | 90.3% (87.7% to 92.7%) | 10,005 |
| Florida | 54.7% (40.2% to 68.6%) | 9.7% (6.3% to 13.9%) | 23.4% (14.8% to 32.1%) | 3.2% (0.4% to 5.6%) | 1.0% (0.0% to 1.9%) | 68.4% (46.5% to 88.0%) | 93.1% (85.5% to 100.0%) | 9,139 |
| New York | 42.7% (36.4% to 48.4%) | 28.3% (22.3% to 33.8%) | 16.1% (13.7% to 19.1%) | 6.2% (3.6% to 8.6%) | 0.8% (0.2% to 1.3%) | 46.6% (38.0% to 54.4%) | 75.8% (70.2% to 80.6%) | 6,732 |
| Pennsylvania | 41.5% (15.8% to 67.7%) | 9.5% (5.6% to 16.1%) | 40.2% (0.0% to 73.3%) | 0.8% (0.2% to 1.4%) | 0.8% (0.0% to 1.6%) | 55.2% (32.1% to 74.4%) | 80.2% (61.6% to 96.2%) | 6,968 |
| Illinois | 34.7% (8.2% to 62.5%) | 36.5% (13.3% to 59.2%) | 21.4% (0.0% to 43.0%) | 3.1% (1.2% to 5.8%) | 0.7% (0.0% to 1.4%) | 45.5% (33.3% to 55.7%) | 75.8% (61.0% to 87.8%) | 5,150 |
| Georgia | 54.0% (47.4% to 59.5%) | 15.8% (13.5% to 18.7%) | 12.9% (9.1% to 17.2%) | 8.1% (3.2% to 13.7%) | 1.3% (0.8% to 1.8%) | 56.8% (48.6% to 67.7%) | 88.1% (85.3% to 92.1%) | 4,146 |
| New Jersey | 72.4% (70.4% to 76.0%) | 8.1% (6.7% to 9.6%) | 14.3% (10.4% to 17.3%) | 3.7% (2.9% to 4.6%) | 0.3% (0.0% to 1.0%) | 55.4% (44.3% to 64.6%) | 81.3% (70.7% to 90.1%) | 4,802 |
| Ohio | 46.6% (35.6% to 62.3%) | 19.9% (12.7% to 26.6%) | 21.2% (11.5% to 31.2%) | 8.1% (4.5% to 12.7%) | 0.9% (0.0% to 2.1%) | 51.2% (41.0% to 62.0%) | 82.2% (75.1% to 88.6%) | 1,339 |
| Michigan | 59.9% (48.2% to 69.0%) | 10.9% (2.4% to 20.1%) | 16.7% (7.5% to 27.9%) | 7.3% (0.0% to 17.2%) | 0.8% (0.4% to 1.6%) | 47.0% (41.2% to 57.5%) | 79.8% (72.2% to 85.4%) | 1,565 |
Each cell is the model's value with its range in brackets. Method: case path model, version 2. Inputs: yearly counts of resolved federal cases, 2021 to 2025.
Case path estimates: class actions, nationwideEstimated
| Kind of class action | Recorded as settled | Dismissed voluntarily | Dismissed by the court | Decided on a motion before trial | Decided at trial | Resolved within 12 months | Resolved within 24 months | Resolved cases the estimate rests on |
|---|---|---|---|---|---|---|---|---|
| Class actions (all types) | 29.3% (20.8% to 36.9%) | 34.4% (29.0% to 41.7%) | 16.4% (14.7% to 18.5%) | 8.1% (6.1% to 10.2%) | 0.3% (0.1% to 0.4%) | 66.5% (64.3% to 69.2%) | 82.4% (79.2% to 85.1%) | 44,541 |
| Wage, hour and labor class actions | 43.1% (36.0% to 51.3%) | 19.4% (13.8% to 23.3%) | 13.3% (12.1% to 15.2%) | 6.0% (3.9% to 8.7%) | 0.6% (0.0% to 1.5%) | 45.7% (38.6% to 51.3%) | 72.6% (70.8% to 74.9%) | 7,355 |
| Employee benefit (ERISA) class actions | 25.9% (12.7% to 46.0%) | 12.5% (3.6% to 20.5%) | 15.0% (6.6% to 23.3%) | 22.1% (16.7% to 26.3%) | 2.3% (0.0% to 5.9%) | 30.7% (14.9% to 41.5%) | 55.1% (42.2% to 65.6%) | 479 |
| Disability access class actions | 38.9% (30.4% to 45.5%) | 50.2% (44.3% to 56.1%) | 7.8% (5.9% to 9.1%) | 0.7% (0.2% to 1.0%) | 0.0% (0.0% to 0.1%) | 93.8% (92.4% to 95.4%) | 97.9% (94.5% to 100.0%) | 10,815 |
| Other civil rights class actions | 26.6% (22.7% to 29.8%) | 17.5% (12.2% to 22.9%) | 25.8% (19.4% to 31.9%) | 15.9% (12.6% to 20.1%) | 0.9% (0.1% to 1.6%) | 47.1% (41.0% to 53.7%) | 69.4% (66.4% to 72.5%) | 1,875 |
| Consumer credit class actions | 44.2% (30.0% to 52.6%) | 25.9% (18.8% to 30.8%) | 15.6% (5.5% to 26.7%) | 7.6% (4.7% to 11.4%) | 0.2% (0.0% to 0.7%) | 71.2% (53.1% to 81.9%) | 88.7% (76.8% to 96.6%) | 2,776 |
| Telephone consumer protection class actions | 28.4% (20.8% to 35.9%) | 53.2% (34.4% to 67.6%) | 12.7% (7.8% to 19.8%) | 1.7% (0.0% to 3.9%) | 0.0% (0.0% to 0.0%) | 85.5% (67.8% to 100.0%) | 97.1% (92.4% to 100.0%) | 2,804 |
| Securities class actions | 10.3% (4.0% to 16.3%) | 20.0% (3.2% to 39.1%) | 21.9% (7.1% to 41.6%) | 22.8% (15.7% to 30.8%) | 0.1% (0.0% to 0.6%) | 33.0% (20.2% to 50.6%) | 55.6% (38.2% to 77.1%) | 1,528 |
| Antitrust class actions | 21.6% (2.7% to 41.8%) | 13.6% (0.8% to 29.9%) | 37.4% (0.0% to 77.1%) | 10.5% (0.0% to 22.0%) | 0.2% (0.0% to 1.7%) | 26.0% (2.3% to 60.7%) | 35.4% (5.9% to 67.8%) | 810 |
| Contract class actions | 17.5% (12.6% to 22.9%) | 28.6% (14.8% to 43.1%) | 22.6% (13.0% to 35.2%) | 12.7% (0.0% to 29.7%) | 0.3% (0.1% to 0.4%) | 61.6% (34.8% to 82.8%) | 80.4% (68.9% to 89.7%) | 4,699 |
| Fraud and property damage class actions | 14.6% (11.4% to 18.5%) | 41.3% (33.8% to 47.2%) | 17.9% (10.2% to 27.4%) | 12.5% (7.1% to 18.2%) | 0.2% (0.1% to 0.3%) | 60.6% (47.6% to 69.5%) | 81.6% (69.4% to 91.2%) | 4,287 |
| Personal injury class actions | 12.9% (10.3% to 15.8%) | 38.0% (2.7% to 64.2%) | 24.5% (3.5% to 59.9%) | 6.6% (2.1% to 12.1%) | 0.2% (0.0% to 1.3%) | 66.1% (23.0% to 96.9%) | 79.9% (41.6% to 100.0%) | 2,974 |
| Other class actions | 20.3% (13.3% to 28.6%) | 28.8% (10.1% to 45.4%) | 23.3% (18.7% to 29.1%) | 16.7% (6.3% to 30.6%) | 0.3% (0.0% to 0.7%) | 61.8% (50.0% to 71.0%) | 78.1% (67.4% to 86.9%) | 4,139 |
Each cell is the model's value with its range in brackets. Method: case path model, version 2. Inputs: yearly counts of resolved federal cases, 2021 to 2025.
The table below is the model's track record for federal personal injury cases nationwide. For each year it shows what the model would have estimated using only the five years before, and what then happened.
Track record: what the model estimated and what happenedComputed
| What was estimated | Year | Model's estimate (range) | What happened | Inside the range |
|---|---|---|---|---|
| Recorded as settled | 2020 | 53.2% (46.0% to 59.1%) | 47.8% | Yes |
| Recorded as settled | 2021 | 51.5% (44.1% to 58.6%) | 49.8% | Yes |
| Recorded as settled | 2022 | 51.0% (44.1% to 58.6%) | 47.7% | Yes |
| Recorded as settled | 2023 | 49.8% (44.1% to 58.7%) | 48.9% | Yes |
| Recorded as settled | 2024 | 48.7% (46.7% to 50.9%) | 46.7% | Yes |
| Recorded as settled | 2025 | 48.2% (45.1% to 51.4%) | 46.7% | Yes |
| Resolved within 12 months | 2020 | 53.5% (33.7% to 70.2%) | 60.0% | Yes |
| Resolved within 12 months | 2021 | 57.3% (47.1% to 65.7%) | 51.2% | Yes |
| Resolved within 12 months | 2022 | 57.1% (46.3% to 66.0%) | 47.2% | Yes |
| Resolved within 12 months | 2023 | 55.3% (40.2% to 68.0%) | 52.7% | Yes |
| Resolved within 12 months | 2024 | 54.3% (40.2% to 68.0%) | 55.7% | Yes |
| Resolved within 12 months | 2025 | 53.3% (40.8% to 66.4%) | 56.5% | Yes |
Personal injury cases in all federal courts, outside multidistrict litigation.
We tested the model against the past. For each year from 2020 to 2025, we rebuilt it using only the five years before and compared it with what then happened. Across 6,104 such tests, the share that actually followed fell inside the model's range 88% of the time, and the typical gap between the model's value and the actual share was 2.5 percentage points. An earlier version of the range, without the widening the model now applies, held the actual result only 64% of the time, which is why it was widened.
How the model did when tested against past yearsComputed
| What was estimated | Tests | Actual share fell inside the range | Typical gap |
|---|---|---|---|
| Dismissed by the court | 763 | 87% | 3.5 points |
| Dismissed voluntarily | 763 | 85% | 3.5 points |
| Decided on a motion before trial | 763 | 91% | 1.5 points |
| Recorded as settled | 763 | 89% | 5.1 points |
| Decided at trial | 763 | 92% | 0.6 points |
| Resolved within 12 months | 763 | 87% | 5.6 points |
| Resolved within 24 months | 763 | 87% | 3.7 points |
| Resolved within 36 months | 763 | 86% | 1.7 points |
| All measures | 6,104 | 88% | 2.5 points |
A test is one place, one kind of case and one year. The typical gap is the median difference between the model's value and the actual share, in percentage points.
Who wins, and what happens next
The case tree model is our own. It follows a federal personal injury case past its ending: when a court decides the case, who it records as the winner; whether the case is then appealed; and what the court of appeals does. The appeal branches come from matching each district court case to the federal appeals database. Every figure it produces is an estimate with a range. It describes cases as a group and says nothing about any named judge, firm, person or litigation, or about amounts.
Who wins depends heavily on how the case is decided. At trial, the model estimates that the plaintiff wins 55.4% of the time (range 52.4% to 58.4%). When the court decides the case on a motion before trial, such as summary judgment, the plaintiff wins 7.7% of the time (range 5.9% to 9.3%): decisions on a motion are mostly recorded for the defendant. Most cases end neither way; the case path model shows how often each ending happens.
Who wins when a court decides, by kind of caseEstimated
| Kind of case | Plaintiff wins at trial | Plaintiff wins on a motion before trial |
|---|---|---|
| Personal injury (all types) | 55.4% (52.4% to 58.4%) | 7.7% (5.9% to 9.3%) |
| Motor vehicle | 65.3% (49.1% to 88.4%) | 15.4% (7.6% to 23.8%) |
| Medical malpractice | — | 5.8% (0.0% to 14.2%) |
| Product liability | — | 4.0% (0.0% to 9.6%) |
| Health care and pharmaceutical product liability | — | 1.4% (0.0% to 5.6%) |
| Marine | — | 22.3% (0.0% to 65.5%) |
| Assault, libel and slander | — | 5.6% (0.0% to 11.3%) |
| Other personal injury | 52.5% (44.2% to 67.3%) | 6.7% (2.7% to 10.4%) |
Each cell is the model's value with its range in brackets. Method: case tree model, version 1. A dash means too few decisions to estimate. Counts only decisions where the court recorded a winner.
What happens next depends on how the case ended. After a judgment for the defendant, the model estimates 28.4% of cases are appealed (range 24.2% to 32.8%); after a judgment for the plaintiff, 14.9% (range 10.3% to 20.0%). Most appeals leave the result in place: after a judgment for the defendant, 80.8% of appeals decided on the merits are affirmed (range 75.1% to 84.6%). An appeal also takes time: the last column shows the median wait from the district court closing the case to the court of appeals deciding it.
What happens next, by how the case ended in the district courtEstimated
| The case ended in | Appealed | Affirmed, of appeals decided on the merits | Reversed at least in part, of appeals decided on the merits | Median wait for the appeal decision (Computed) |
|---|---|---|---|---|
| A judgment for the plaintiff | 14.9% (10.3% to 20.0%) | 74.0% (41.3% to 100.0%) | 26.0% (0.0% to 58.7%) | 534 days |
| A judgment for the defendant | 28.4% (24.2% to 32.8%) | 80.8% (75.1% to 84.6%) | 19.2% (15.4% to 24.9%) | 417 days |
| A dismissal by the court | 7.0% (6.7% to 7.2%) | 84.6% (76.5% to 92.7%) | 15.4% (7.3% to 23.5%) | 434 days |
| A recorded settlement or a voluntary dismissal | 1.3% (0.9% to 1.9%) | — | — | 773 days |
Federal personal injury cases nationwide. The first three columns are Estimated, each with its range in brackets; the last is Computed. The record does not say which side appealed. A reversal often sends the case back for more proceedings; it does not mean the other side won. Appeals that were dismissed, withdrawn or are still pending are not in the affirmed and reversed columns.
Some features of a case recorded when it is filed go with very different endings. The largest difference in the table below is whether the plaintiff has a lawyer: from 2021 to 2025, 51.8% of cases where the plaintiff had a lawyer were recorded as settled and 18.0% were dismissed by the court; where the plaintiff had no lawyer, 7.1% were recorded as settled and 60.2% were dismissed by the court. These are counts of what happened, not the effect of any one feature: cases with and without lawyers differ in many other ways.
How personal injury cases ended, by kind of case, 2021 to 2025Computed
| Kind of case, as recorded at filing | Cases resolved | Recorded as settled | Dismissed voluntarily | Dismissed by the court | Judgment for the plaintiff | Judgment for the defendant | Median days to closing |
|---|---|---|---|---|---|---|---|
| Did the plaintiff have a lawyer? | |||||||
| Plaintiff had a lawyer | 90,289 | 51.8% | 19.9% | 18.0% | 1.9% | 4.5% | 362 |
| Plaintiff had no lawyer | 8,452 | 7.1% | 7.6% | 60.2% | 0.9% | 18.9% | 154 |
| Where did the case start? | |||||||
| Filed in federal court | 50,016 | 41.3% | 21.1% | 24.6% | 2.5% | 6.0% | 355 |
| Removed from a state court | 41,593 | 56.1% | 17.0% | 17.3% | 1.0% | 5.2% | 350 |
| Was a jury asked for? | |||||||
| A jury was asked for | 83,913 | 50.2% | 18.9% | 19.9% | 1.6% | 5.3% | 356 |
| No jury was asked for | 14,828 | 35.0% | 18.2% | 31.2% | 2.9% | 8.3% | 277 |
| Why is the case in federal court? | |||||||
| The parties are from different states | 73,858 | 51.1% | 19.3% | 19.6% | 1.5% | 4.8% | 353 |
| A question of federal law | 16,230 | 38.2% | 15.2% | 29.5% | 2.9% | 8.0% | 298 |
| The United States is the defendant | 8,590 | 39.7% | 21.0% | 24.1% | 2.4% | 9.8% | 347 |
Federal personal injury cases nationwide, outside multidistrict litigation. Shares are of cases resolved. The differences are associations in the record, not causes.
We tested the case tree the same way as our other models: each branch was rebuilt for past years from the five years before and compared with what happened. Across 1,371 tests, the actual share fell inside the model's range 91% of the time, with a typical gap of 1.4 percentage points.
How the case tree did when tested against past yearsComputed
| Branch | Tests | Actual share fell inside the range | Typical gap |
|---|---|---|---|
| Affirmed, after a dismissal by the court | 9 | 89% | 4.8 points |
| Affirmed, after a judgment for the defendant | 8 | 100% | 2.0 points |
| Affirmed, after a judgment for the plaintiff | 4 | 75% | 7.7 points |
| Appealed, after a dismissal by the court | 295 | 93% | 2.5 points |
| Appealed, after a judgment for the defendant | 128 | 93% | 4.0 points |
| Appealed, after a judgment for the plaintiff | 36 | 94% | 3.1 points |
| Appealed, after a recorded settlement or a voluntary dismissal | 722 | 91% | 0.8 points |
| Plaintiff wins on a motion | 130 | 86% | 2.6 points |
| Plaintiff wins at trial | 18 | 83% | 5.7 points |
| All branches | 1,371 | 91% | 1.4 points |
A test is one place, one kind of case and one year. Branches with few tests rest on few years and should be read with more caution.
Filings outlook for 2026 and 2027
The federal case file covers 2025 in full and 2026 up to 30 June 2026. The filings outlook is our own estimate of where 2026 will end, built from what has been filed so far, and a much rougher estimate for 2027. Both are shown as a value with a range and are labelled Estimated.
Filings outlook: nationwide, by kind of caseEstimated
| Kind of case | Filed in 2025 | Filed to 30 June 2026 | Estimate for 2026 (range) | Estimate for 2027 (range) |
|---|---|---|---|---|
| Personal injury (all types) | 26,757 | 13,617 | 27,755 (25,191 to 29,874) | 27,885 (22,198 to 40,214) |
| Motor vehicle | 6,915 | 3,456 | 6,937 (6,746 to 7,193) | 7,372 (6,558 to 8,022) |
| Motor vehicle product liability | 285 | 152 | 340 (251 to 416) | 356 (184 to 580) |
| Medical malpractice | 853 | 459 | 906 (726 to 1,063) | 882 (600 to 1,164) |
| Product liability | 2,709 | 1,521 | 3,021 (2,216 to 3,983) | 3,043 (1,387 to 5,791) |
| Health care and pharmaceutical product liability | 388 | 175 | 365 (251 to 439) | 280 (128 to 497) |
| Asbestos | 71 | 43 | 91 (69 to 111) | 80 (47 to 103) |
| Aviation | 324 | 207 | 408 (273 to 518) | 529 (140 to 724) |
| Marine | 1,145 | 603 | 1,211 (865 to 1,452) | 1,183 (591 to 2,132) |
| Railroad employee injury | 310 | 140 | 274 (210 to 340) | 263 (195 to 372) |
| Assault, libel and slander | 777 | 384 | 761 (707 to 826) | 771 (648 to 990) |
| Other personal injury | 12,980 | 6,477 | 13,459 (11,130 to 16,334) | 13,172 (9,398 to 27,236) |
| Class actions (all types) | 10,589 | 6,012 | 11,864 (11,025 to 12,526) | 11,820 (10,263 to 13,738) |
Method: filings outlook, version 1. The first two columns are Computed from court records; the last two are Estimated. The estimate for 2027 is much less certain than the one for 2026.
Filings outlook: personal injury cases in ten large statesEstimated
| State | Filed in 2025 | Filed to 30 June 2026 | Estimate for 2026 (range) | Estimate for 2027 (range) |
|---|---|---|---|---|
| California | 2,400 | 1,500 | 3,217 (2,634 to 3,881) | 3,339 (2,235 to 4,979) |
| Texas | 3,081 | 1,595 | 3,305 (2,985 to 3,614) | 3,624 (2,573 to 4,343) |
| Florida | 2,401 | 1,380 | 2,841 (2,527 to 3,192) | 2,691 (1,867 to 4,805) |
| New York | 1,653 | 909 | 1,839 (1,579 to 2,194) | 1,741 (1,431 to 2,746) |
| Pennsylvania | 1,195 | 735 | 1,524 (1,327 to 1,702) | 1,398 (979 to 1,916) |
| Illinois | 1,516 | 666 | 1,337 (699 to 2,218) | 1,561 (400 to 4,299) |
| Georgia | 1,237 | 562 | 1,117 (965 to 1,288) | 1,227 (824 to 1,471) |
| New Jersey | 1,154 | 560 | 1,092 (1,002 to 1,175) | 1,097 (936 to 1,299) |
| Ohio | 326 | 143 | 290 (242 to 342) | 301 (205 to 393) |
| Michigan | 480 | 201 | 407 (370 to 441) | 458 (345 to 583) |
Method: filings outlook, version 1. The first two columns are Computed from court records; the last two are Estimated. The estimate for 2027 is much less certain than the one for 2026.
Filings outlook: class actions in ten large statesEstimated
| State | Filed in 2025 | Filed to 30 June 2026 | Estimate for 2026 (range) | Estimate for 2027 (range) |
|---|---|---|---|---|
| California | 3,032 | 1,824 | 3,648 (3,080 to 4,211) | 3,799 (2,494 to 6,362) |
| Texas | 492 | 382 | 779 (644 to 945) | 746 (539 to 1,599) |
| Florida | 218 | 101 | 185 (137 to 230) | 237 (69 to 310) |
| New York | 2,173 | 906 | 1,698 (1,534 to 1,864) | 1,516 (1,239 to 1,989) |
| Pennsylvania | 462 | 236 | 481 (307 to 692) | 529 (273 to 804) |
| Illinois | 71 | 55 | 122 (77 to 167) | 110 (62 to 272) |
| Georgia | 291 | 92 | 170 (125 to 213) | 197 (107 to 342) |
| New Jersey | 318 | 195 | 375 (299 to 460) | 359 (222 to 573) |
| Ohio | 268 | 124 | 240 (171 to 346) | 230 (119 to 388) |
| Michigan | 264 | 115 | 232 (190 to 272) | 238 (147 to 353) |
Method: filings outlook, version 1. The first two columns are Computed from court records; the last two are Estimated. The estimate for 2027 is much less certain than the one for 2026.
We tested the outlook by rebuilding it for each past year as if that year were under way. For the year under way, the number of cases actually filed fell inside the range 90% of the time across 862 tests, and the typical gap between the estimate and the actual number was 7% of the actual number. For the year after, it fell inside the range 87% of the time across 694 tests, with a typical gap of 18%; that is why its ranges are wide.
How the filings outlook did when tested against past yearsComputed
| Estimate for | Tests | Actual filings fell inside the range | Typical gap |
|---|---|---|---|
| The year under way | 862 | 90% | 7% of actual filings |
| The year after | 694 | 87% | 18% of actual filings |
A test is one place, one kind of case and one year.
The outlook cannot foresee a sudden wave of filings, such as a new mass litigation or a change in the law. It leaves out multidistrict litigation, where one litigation can add tens of thousands of cases in a year, and it says nothing about any single case, firm, judge or litigation.
What this report cannot tell you
- Settlement amounts are mostly not public. Court records show that a case settled, not for how much. The only amounts here are those a company stated in a public filing, and New York City's own published payments; a litigation with no amount listed may still have settled.
- The federal figures cover federal courts. Most injury cases are filed in state courts, and only three of the ten states we cover publish how those cases end.
- Endings are as the courts recorded them. 'Settled' is recorded unevenly, and many voluntary dismissals follow a settlement.
- Counts by litigation rely on the docket number courts attach to each case, which is not attached to every case.
- Class action counts are of cases with class allegations, not certified classes.
- Figures labelled Estimated come from a named method and are always shown as a range. No estimate is made about a named firm, attorney, person or litigation.
- Nothing in this report is legal advice or a prediction about any individual case.
41 tables. The report is rebuilt from the source files each time the site's data is rebuilt.
Sources
Last updated 18 November 2026. That is the date we last retrieved the source files below.
- Federal Judicial Center Integrated Database (civil, 1988 forward) File retrieved 18 November 2026 from fjc.gov. File fingerprint 74405231a9a3.
- Federal Judicial Center Integrated Database (appeals, 2008 forward) File retrieved 18 November 2026 from fjc.gov. File fingerprint 05d545060b09.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 18 November 2026 from jpml.uscourts.gov. File fingerprint 2854e718c8e5.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 18 November 2026 from jpml.uscourts.gov. File fingerprint da59f7201dce.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 18 November 2026 from jpml.uscourts.gov. File fingerprint d7b1dfe51c95.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 18 November 2026 from jpml.uscourts.gov. File fingerprint 75c7f211b515.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 5e47f97d1bd3.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 25f6d8164c8f.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 7e163afc283c.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint b08ca308ec42.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint e2e5c50c81d9.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint fa00a99259e1.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint a906a280c128.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 2962ebe94b8b.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 8ec2dc051fa2.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint d6cad2004cae.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 4c8c598b9758.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 02acf48f3753.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 06530a1c2eba.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint f9835afbad7a.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint beecdb1fcbd3.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 68ffe884f3c4.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 8d89078404ff.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 6bdcea2af28e.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 1aa2181acd5a.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 1c5e7f62c95a.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 1113fa70c312.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 16 November 2026 from jpml.uscourts.gov. File fingerprint 9e1e4117add7.
- U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics Report: pending MDL dockets File retrieved 18 November 2026 from jpml.uscourts.gov. File fingerprint aa153fa65373.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint fc08381512fc.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint 16ee69f6a692.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint 8b6ad68afe5f.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint c6bb46376bfe.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint b1b398899e1c.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint 771ed43027c2.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint b514c6e22692.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint 610c50967d8a.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint eb409fb61400.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint 67e425143d1a.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint 5487c0c14b37.
- U.S. Securities and Exchange Commission, EDGAR company filings File retrieved 16 November 2026 from sec.gov. File fingerprint 3da6296539e4.
- CourtListener bulk data: dockets (Free Law Project) File retrieved 16 November 2026 from storage.courtlistener.com. File fingerprint f40588851cee.
- Federal Judicial Center, Biographical Directory of Article III Federal Judges File retrieved 18 November 2026 from fjc.gov. File fingerprint d2026337b56d.
- NYC Law Department: Case-Related Information About Civil Litigation (NYC Open Data) File retrieved 18 November 2026 from data.cityofnewyork.us. File fingerprint 7c8a2c3289a8.
- Judicial Council of California, 2026 Court Statistics Report File retrieved 18 November 2026 from courts.ca.gov. File fingerprint d65646558a5f.
- Texas Office of Court Administration, Annual Statistical Report, Fiscal Year 2025 File retrieved 18 November 2026 from txcourts.gov. File fingerprint 0a338a0d6946.
- Michigan State Court Administrative Office, 2023 Court Caseload Report (statewide) File retrieved 18 November 2026 from courts.michigan.gov. File fingerprint 957abfec4000.
How the estimates on this page were made
Case path model. Our own model of how a kind of case tends to end and how long it takes. For one kind of case in one place, it takes every such case resolved in the federal courts there over the last five complete years and works out the share that ended each way (recorded as settled, dismissed voluntarily, dismissed by the court, decided on a motion before trial, decided at trial) and the share resolved within one, two and three years of filing. The value shown is the share over all five years together. The range starts from the lowest and highest single years and is then widened at each end by half the gap between them, because testing showed the unwidened range was too narrow: we rebuilt the model for each year from 2020 on using only the five years before it, and the share that actually followed fell inside the unwidened range about 64% of the time and inside the widened range about 88% of the time. The test results are published with the model. An estimate is produced only when each of the five years has at least 50 resolved cases. Limits: it describes cases as a group, as the courts recorded their endings. A voluntary dismissal often follows a settlement, and the record does not say which. It covers federal courts only; state courts may differ. It does not predict any single case, and it says nothing about amounts. More on this method.
The full address of every source file is on the sources page. Found something wrong? See corrections and removal requests. How figures are labelled and calculated is in the methodology.